Last reviewed · How we verify
Retinoids
At a glance
| Generic name | Retinoids |
|---|---|
| Sponsor | Erasmus Medical Center |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma (PHASE3)
- Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma (PHASE1)
- Comparison of a New Masterful Preparation to Kligman's Trio in the Treatment of Melasma (PHASE2)
- Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart Failure (NA)
- Pilot Trial of Supplemental Vitamin A and Nicotinamide (EARLY_PHASE1)
- Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) (PHASE1, PHASE2)
- Isotretinoin vs hCG for Male Infertility Due to Low or Absent Sperm (PHASE2)
- Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Retinoids CI brief — competitive landscape report
- Retinoids updates RSS · CI watch RSS
- Erasmus Medical Center portfolio CI